Status | Study |
Recruiting |
Study Name: Ruxolitinib Phosphate in Treating Patients With Chronic Neutrophilic Leukemia or Atypical Chronic Myeloid Leukemia Condition: Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Chronic Neutrophi Date: 2014-03-18 Interventions: Other: Laboratory Biomarker Analysis |
Withdrawn |
Study Name: Mechanical Stimulation in Preventing Bone Density Loss in Patients Undergoing Donor Stem Cell Transplant Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2012-03-16 Interventions: Procedure: management of therapy complications |
Completed |
Study Name: Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia Condition: Adult Acute Lymphoblastic Leukemia Adult Acute Myeloid Leukemia Date: 2011-10-21 Interventions: Drug: cefepime hydrochloride Given IV Other Names: |
Recruiting |
Study Name: A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies Condition: Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Date: 2011-06-27 Interventions: Drug: Fludarabine Given IV |
Withdrawn |
Study Name: Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Condition: Cancer Date: 2011-03-15 Interventions: Drug: ketamine hydrochloride Other: pharma |
Completed |
Study Name: Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant Condition: Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remi Date: 2011-02-25 Interventions: Drug: supersaturated calcium phosphate rinse |
Completed |
Study Name: Palifermin in Preventing Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer Condition: Accelerated Phase Chronic Myelogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remissi Date: 2010-11-02 Interventions: Biological: palifermin Given I |
Completed |
Study Name: MK2206 in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Leukemia Condition: Accelerated Phase Chronic Myelogenous Leukemia Acute Leukemias of Ambiguous Lineage Date: 2010-10-29 Interventions: Drug: Akt inhibitor MK2206 Giv |
Completed |
Study Name: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant Condition: Hematopoietic/Lymphoid Cancer Accelerated Phase Chronic Myelogenous Leukemia Date: 2010-09-08 Interventions: Procedure: infection prophylaxis and management |
Terminated |
Study Name: Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload Condition: Iron Overload Accelerated Phase Chronic Myelogenous Leukemia Date: 2010-07-06 Interventions: Drug: deferasirox Given orally Other Names: |